This report provides comprehensive information on the current therapeutic developmental pipeline of Vernalis plcs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Get Detail Report With TOC @ http://www.researchmoz.us/vernalis-plc-product-pipeline-review-2014-report.html The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

1. Vernalis plc - Product Pipeline Review - 2014
Vernalis plc - Product Pipeline Review - 2014
Summary
Global Markets Directs, Vernalis plc - Product Pipeline Review - 2014, provides an overview of the Vernalis plcs pharmaceutical research and development
focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Vernalis plcs, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest
updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of Vernalis plc including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Vernalis plcs human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major
milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Vernalis plcs pipeline products
Reasons to buy
- Evaluate Vernalis plcs strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Vernalis plc in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Vernalis plcs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Vernalis plc and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vernalis plc
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope
- Explore the dormant and discontinued projects of Vernalis plc and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 4
vernalis Plc Snapshot 5
vernalis Plc Overview 5
key Information 5
key Facts 5
vernalis Plc - Research And Development Overview 6
key Therapeutic Areas 6
vernalis Plc - Pipeline Review 8
pipeline Products By Stage Of Development 8
pipeline Products - Monotherapy 9
pipeline Products - Partnered Products 10
partnered Products/combination Treatment Modalities 11
pipeline Products - Out-licensed Products 12
Vernalis plc - Product Pipeline Review - 2014

2. out-licensed Products/combination Treatment Modalities 13
vernalis Plc - Pipeline Products Glance 14
vernalis Plc - Clinical Stage Pipeline Products 14
phase Ii Products/combination Treatment Modalities 14
vernalis Plc - Early Stage Pipeline Products 15
discovery Products/combination Treatment Modalities 15
vernalis Plc - Drug Profiles 16
v-158866 16
product Description 16
mechanism Of Action 16
r&d Progress 16
v-81444 17
product Description 17
mechanism Of Action 17
r&d Progress 17
small Molecule To Inhibit Chk1 For Oncology 18
product Description 18
mechanism Of Action 18
r&d Progress 18
vernalis Plc - Pipeline Analysis 19
vernalis Plc - Pipeline Products By Target 19
vernalis Plc - Pipeline Products By Route Of Administration 20
vernalis Plc - Pipeline Products By Molecule Type 21
vernalis Plc - Pipeline Products By Mechanism Of Action 22
vernalis Plc - Recent Pipeline Updates 23
vernalis Plc - Dormant Projects 25
vernalis Plc - Discontinued Pipeline Products 26
discontinued Pipeline Product Profiles 26
alphadolone 26
bb-2827 26
indantadol 26
marimastat 26
solimastat 27
v-1003 27
v-10153 27
v-24343 27
vml-670 27
vernalis Plc - Company Statement 28
vernalis Plc - Locations And Subsidiaries 29
head Office 29
other Locations & Subsidiaries 29
appendix 30
methodology 30
coverage 30
secondary Research 30
primary Research 30
expert Panel Validation 30
contact Us 31
disclaimer 31
list Of Tables
vernalis Plc, Key Information 5
vernalis Plc, Key Facts 5
vernalis Plc - Pipeline By Indication, 2014 7
vernalis Plc - Pipeline By Stage Of Development, 2014 8
vernalis Plc - Monotherapy Products In Pipeline, 2014 9
vernalis Plc - Partnered Products In Pipeline, 2014 10
vernalis Plc - Partnered Products/ Combination Treatment Modalities, 2014 11
vernalis Plc - Out-licensed Products In Pipeline, 2014 12
vernalis Plc - Out-licensed Products/ Combination Treatment Modalities, 2014 13
vernalis Plc - Phase Ii, 2014 14
vernalis Plc - Discovery, 2014 15
vernalis Plc - Pipeline By Target, 2014 19
vernalis Plc - Pipeline By Route Of Administration, 2014 20
vernalis Plc - Pipeline By Molecule Type, 2014 21
vernalis Plc - Pipeline Products By Mechanism Of Action, 2014 22
vernalis Plc - Recent Pipeline Updates, 2014 23
vernalis Plc - Dormant Developmental Projects,2014 25
Vernalis plc - Product Pipeline Review - 2014

3. vernalis Plc - Discontinued Pipeline Products, 2014 26
vernalis Plc, Subsidiaries 29
list Of Figures
vernalis Plc - Pipeline By Top 10 Indication, 2014 7
vernalis Plc - Pipeline By Stage Of Development, 2014 8
vernalis Plc - Monotherapy Products In Pipeline, 2014 9
vernalis Plc - Partnered Products In Pipeline, 2014 10
vernalis Plc - Out-licensed Products In Pipeline, 2014 12
vernalis Plc - Pipeline By Top 10 Target, 2014 19
vernalis Plc - Pipeline By Top 10 Route Of Administration, 2014 20
vernalis Plc - Pipeline By Top 10 Molecule Type, 2014 21
vernalis Plc - Pipeline Products By Top 10 Mechanism Of Action, 2014 22
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Vernalis plc - Product Pipeline Review - 2014